Sign In
Buy ABT
$90.53
+2.76 (+3.14%)
At Close: Jun 23, 2026
21 Bold Words from Abbott's CEO About the Future of Its COVID Tests
10:30am, Saturday, 23'rd Apr 2022 The Motley Fool
Will sales plummet once the coronavirus shifts from being a pandemic-level threat to an endemic illness?
21 Bold Words from Abbott's CEO About the Future of Its COVID Tests
06:30am, Saturday, 23'rd Apr 2022
Will sales plummet once the coronavirus shifts from being a pandemic-level threat to an endemic illness?
Abbot tops first-quarter EPS by $0.26
02:52pm, Friday, 22'nd Apr 2022
Abbot (NYSE: ABT) records a first-quarter EPS of $1.73, beating analyst estimates of $1.47 by 25 cents. The company recorded a first-quarter revenue of about $11.9 billion, which also topped the $11.
This Medical Devices Company Is A Better Pick Over Abbott Stock
08:00am, Friday, 22'nd Apr 2022
We think that Stryker Corp. stock (NYSE: SYK) currently is a better pick compared to its industry peer, Abbott stock (NYSE: ABT), despite it being the more expensive of the two, trading at 6.1x traili
7 Stocks to Buy If You Think Inflation Is Topping Out
06:15am, Friday, 22'nd Apr 2022
Some analysts believe that the market may have seen peak inflation. Here are seven stocks to buy if inflation is at, or near, its peak The post 7 Stocks to Buy If You Think Inflation Is Topping Out ap
What Does Raymond James, Wells Fargo Have To Say On Abbott's Q1 Earnings
07:43pm, Thursday, 21'st Apr 2022 Benzinga
Raymond James thinks Abbott Laboratories' (NYSE: ABT) 1Q results were solid and demonstrated the durable nature of ABT's portfolio, as three out of four business segments grew over 10% organica
Got $5,000? This Dividend King Is Down More Than 15% This Year
03:15pm, Thursday, 21'st Apr 2022 The Motley Fool
Make the most of your money by investing in this top income stock.
Expert Ratings for Abbott Laboratories
01:28pm, Thursday, 21'st Apr 2022 Benzinga
Abbott Laboratories (NYSE:ABT) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
5
0
0
0
Last
Company News for Apr 21, 2022
12:52pm, Thursday, 21'st Apr 2022 Zacks Investment Research
Companies In The News Are: PG, ABT, ANTM, BKR
Abbott predicts fewer sales of COVID-19 tests in 2022 but says the business of at-home tests isn't going away
12:45pm, Thursday, 21'st Apr 2022 MarketWatch
Abbott Laboratories made $3.3 billion in revenue from its COVID-19 tests in the first three months of the year.
Face-mask issue remains hot COVID topic as poll finds most Americans support their use on public transport and DoJ awaits CDC's decision
11:25am, Thursday, 21'st Apr 2022 MarketWatch
A new survey has found that most Americans still support wearing face masks on airplanes and other shared public transportation, after a ruling by a federal judge upended the mandate.
Highly Valued Abbot Laboratories Could Move Lower
05:27am, Thursday, 21'st Apr 2022 Investing.com
Abbott Laboratories (ABT) Q1 2022 Earnings Call Transcript
07:00pm, Wednesday, 20'th Apr 2022 The Motley Fool
ABT earnings call for the period ending March 31, 2022.
Abbott Laboratories reports a 14% YoY increase in Q1 sales
06:00pm, Wednesday, 20'th Apr 2022
Abbott Laboratories reported its financial results for the first quarter on Wednesday. Here's what you should know.
Abbott's (ABT) Q1 Earnings and Revenues Exceed Estimates
02:23pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Within Adult Nutrition, Abbott (ABT) gains from the strong performance of Ensure and Glucerna brands in Q1.
